Usami Masahide
Department of Child and Adolescent Psychiatry, Kohnodai Hospital, National Center for Global Health and Medicine, Ichikawa, Japan.
Clinical Center for Children's Mental Health, Kohnodai Hospital, National Center for Global Health and Medicine, Ichikawa, Japan.
GHM Open. 2024 Nov 30;4(2):54-58. doi: 10.35772/ghmo.2023.01016.
The Japanese government established the Children and Family Agency in April 2023 and is trying to promote evidence-based policymaking (EBPM). However, the current state of child and adolescent psychiatry in Japan demonstrated some difficulties. School refusal and suicide problems are increasing after the coronavirus disease-2019 (COVID-19) pandemic. These issues need to be addressed, thereby warranting various policies to be developed and implemented. Increasing the number of inpatient medical institutions and establishing a community-based data accumulation system that enables data and knowledge sharing among professionals is essential to improve child and adolescent psychiatric care. Furthermore, EBPM is needed to effectively develop a policy, and specialized experts are necessary to organize data and critically review evidence.
日本政府于2023年4月设立了儿童与家庭机构，并试图推动基于证据的政策制定（EBPM）。然而，日本目前儿童和青少年精神病学的状况显示出一些困难。2019冠状病毒病（COVID-19）大流行后，学校拒学和自杀问题不断增加。这些问题需要得到解决，因此有必要制定和实施各种政策。增加住院医疗机构的数量，并建立一个基于社区的数据积累系统，以实现专业人员之间的数据和知识共享，对于改善儿童和青少年精神科护理至关重要。此外，需要基于证据的政策制定来有效地制定政策，并且需要专业专家来整理数据并严格审查证据。
